%D8%B3%D9%8A%D8%B1%D9%88%D9%84%D9%8A%D9%85%D9%88%D8%B3%D8%B3%DB%8C%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3Category:SirolimusSirolimusSirolimusSirolimus%D8%B3%DB%8C%D8%B1%D9%88%D9%84%DB%8C%D9%85%D9%88%D8%B3SirolimuusiSirolimus%D7%A8%D7%A4%D7%9E%D7%99%D7%A6%D7%99%D7%9FSirolimus%E3%83%A9%E3%83%91%E3%83%9E%E3%82%A4%E3%82%B7%E3%83%B3%EC%8B%9C%EB%A1%A4%EB%A6%AC%EB%AC%B4%EC%8A%A4SirolimusSirolimusSirolimus%D0%A1%D0%B8%D1%80%D0%BE%D0%BB%D0%B8%D0%BC%D1%83%D1%81SirolimusRapamycinSirolimSirolimus%D0%A1%D0%B8%D1%80%D0%BE%D0%BB%D1%96%D0%BC%D1%83%D1%81SirolimusQ32089%E9%9B%B7%E5%B8%95%E9%9C%89%E7%B4%A0
about
P3781
The Impact of Everolimus Based Immunosuppression in the Evolution of Hepatitis C Fibrosis After Liver TransplantationComparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney TransplantationMolecular Profiling-Based Targeted Therapy in Treating Patients With Advanced Solid TumorsCombination Chemotherapy With or Without Temsirolimus in Treating Patients With Intermediate Risk RhabdomyosarcomaXIENCE Xpedition Everolimus-Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE Xpedition SV Japan PMS)The Study of Active Transfer of Plaque Technique for Unprotected Distal Left Main Bifurcation LesionsAuranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung CancerDirect Complete Versus Staged Complete Revascularization in Patients Presenting With Acute Coronary Syndromes and Multivessel DiseaseTrial of eRapa in Prostate Cancer PatientsA First-in-Man Study to Evaluate the Feasibility and Safety of Sirolimus-eluting Iron Bioresorbable Coronary Scaffold SystemCD40-L Blockade for Prevention of Acute Graft-Versus-Host DiseaseBIOFLOW-SV All Comers RegistryBIOFLOW-SV Portugal RegistryImmunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation FailureNCT Neuro Master Match - N²M² (NOA-20)Evaluation of the Safety and Tolerability of Niraparib With Everolimus in Ovarian and BreastErlotinib and RAD001 (Everolimus) in Patients With Previously Treated Advanced Pancreatic CancerEverolimus (RAD001) in Elderly Patients With Acute Myeloid LeukemiaABI-009 Trial in Patients With Advanced Non-hematologic MalignanciesEvaluation of Early Conversion to Everolimus From Cyclosporine in de Novo Renal Transplant RecipientsA Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform NeurofibromasComparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaDiabetes Drug Eluting Sirolimus Stent Experience in Restenosis TrialXIENCE V: SPIRIT WOMENA Study of Diabetic Patients With De Novo Native Coronary Artery LesionsStudy Evaluating The Safety, Efficacy & Pharmacokinetics Of Temsirolimus(CCI-779) In Subjects With Advanced Renal Cell CarcinomaFibrosis in Renal AllograftsRandomized Trial Comparing Titan Stent With Zotarolimus-Eluting StentSirolimus Treatment in Patients With Autosomal Dominant Polycystic Kidney Disease: Renal Efficacy and SafetyTrial of Efficacy and Safety of Sirolimus in Tuberous Sclerosis and LAMNon-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood DisordersFeasibility Study With the Sirolimus-Eluting BX Velocity Balloon-Expandable Stent in the Treatment of Diabetic Patients With Native Coronary Artery LesionsDiffuse Type In-Stent Restenosis After Drug-Eluting StentFocal In-stent Restenosis After Drug-Eluting StentCombination of RAD001 and Erlotinib in Patients With Advanced Non Small Cell Lung Cancer Previously Treated Only With ChemotherapyA Phase II Study of Belatacept (BMS-224818) With a Steroid-free Regimen in Subjects Undergoing Kidney TransplantationComparison of Stent Graft, Sirolimus Stent, and Bare Metal Stent Implanted in Patients With Acute Coronary SyndromeStudy Evaluating of Calcineurin Inhibitors Versus Sirolimus in Renal Allograft RecipientSirolimus in Treating Patients With HIV-Related Kaposi's SarcomaEverolimus (RAD001) as Therapy for Patients With Systemic Mastocytosis
P4844
cellular response to rapamycinresponse to rapamycinAllograft RejectionSorafenib / Sirolimus combination therapyCetuximab / Sirolimus combination therapySirolimus / Erlotinib combination therapySirolimus / afatinib combination therapySirolimus / pd-0325901 combination therapySynaptic signaling pathways associated with autism spectrum disorderHead and Neck Squamous Cell Carcinoma
P527
Everolimus-eluting stents in interventional cardiologyNext-generation drug-eluting stents in coronary artery disease: focus on everolimus-eluting stent (Xience V)The mTOR inhibitor rapamycin has limited acute anticonvulsant effects in mice.Enteric-delivered rapamycin enhances resistance of aged mice to pneumococcal pneumonia through reduced cellular senescenceVisible effects of rapamycin (sirolimus) on human skin explants in vitro.Safety of mTOR inhibitor continuation in pediatric heart transplant recipients undergoing surgical procedures.Clinical application of molecular genetics in lymphatic malformationsTopical use of mammalian target of rapamycin inhibitors in dermatology: A systematic review with meta-analysisGiant Pelvic Neurofibroma in Patient with Plexiform Sciatic Neurofibroma and Neurofibromatosis Type 1Outcomes of treatment with sirolimus for non-infectious uveitis: a meta-analysis and systematic reviewComparative preclinical evaluation of a polymer-free sirolimus-eluting stent in porcine coronary arteriesSirolimus: Efficacy and Complications in Children With Hyperinsulinemic Hypoglycemia: A 5-Year Follow-Up StudyTargeting mTOR with MLN0128 Overcomes Rapamycin and Chemoresistant Primary Effusion LymphomaChylous Manifestations and Management of Gorham-Stout SyndromeEffects of Sirolimus on Lung function in patients with Lymphangioleiomyomatosis
P921
description
chemesch Verbindung
@lb
chemical compound
@en-ca
chemical compound
@en-gb
chemická sloučenina
@cs
chemická zlúčenina
@sk
chemiese verbinding
@af
chemische Verbindung
@de
chemische Verbindung
@de-ch
chemische verbinding
@nl
component quimic
@oc
name
Sirolim
@sl
Sirolimus
@ca
Sirolimus
@de
Sirolimus
@es
Sirolimus
@nl
Sirolimus
@oc
Sirolimus
@pt
Sirolimus
@sh
Sirolimus
@vi
Sirolimuusi
@fi
type
label
Sirolim
@sl
Sirolimus
@ca
Sirolimus
@de
Sirolimus
@es
Sirolimus
@nl
Sirolimus
@oc
Sirolimus
@pt
Sirolimus
@sh
Sirolimus
@vi
Sirolimuusi
@fi
altLabel
(-)-Rapamycin
@cy
(-)-rapamycin
@en
53123-88-9
@fr
AY-22989
@cy
AY-22989
@en
C51H79N1O13
@it
C51H79NO13
@fr
Rapamicin
@sl
Rapamicina
@es
Rapamicina
@it
prefLabel
Sirolim
@sl
Sirolimus
@ca
Sirolimus
@de
Sirolimus
@es
Sirolimus
@nl
Sirolimus
@oc
Sirolimus
@pt
Sirolimus
@sh
Sirolimus
@vi
Sirolimuusi
@fi